Patents by Inventor Oliver-Martin Fischer

Oliver-Martin Fischer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ESTRA-1,3,5(10),16-TETRAENE-3-CARBOXAMIDES FOR INHIBITION OF 17.BETA.-HYDROXYSTEROID DEHYDROGENASE (AKR1 C3)
    Publication number: 20160024142
    Abstract: The invention relates to AKR1C3 inhibitors of formula (I) and to processes for preparation thereof, to the use thereof for treatment and/or prophylaxis of diseases and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of bleeding disorders and endometriosis.
    Type: Application
    Filed: February 18, 2014
    Publication date: January 28, 2016
    Applicant: BAYER PHARMA AKTIENGESELLSCHAFT
    Inventors: Ulrich BOTHE, Matthias BUSEMANN, Naomi BARAK, Andrea ROTGERI, Oliver Martin FISCHER, Tobias MARQUARDT
  • 3-SUBSTITUTED ESTRA-1,3,5(10),16-TETRAENE DERIVATIVES, METHODS FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING SAME, AND USE THEREOF FOR THE PRODUCTION OF MEDICAMENTS
    Publication number: 20150210734
    Abstract: The invention relates to AKR1C3 inhibitors and to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular bleeding disorders and endometriosis.
    Type: Application
    Filed: July 5, 2013
    Publication date: July 30, 2015
    Inventors: Ulrich Bothe, Matthias Busemann, Oliver Martin Fischer, Naomi Barak, Andrea Rotgeri, Tobias Marquardt, Christian Stegmann
  • 18-METHYL-6,7-METHYLENE-3-OXO-17-PREGN-4-ENE-21,17B-CARBOLACTONES, PHARMACEUTICAL PREPARATIONS COMPRISING SAID COMPOUNDS AND USE THEREOF IN THE TREATMENT OF ENDOMETRIOSIS
    Publication number: 20140288035
    Abstract: The present invention relates to 18-methyl-6,7-methylene-17-pregn-4-ene-21,17?-carbolactones of general formula I wherein the 6,7-methylene group can be in ?- or ? position, pharmaceutical preparations containing at least one isomer of formula I and use thereof in the treatment of endometriosis.
    Type: Application
    Filed: November 2, 2012
    Publication date: September 25, 2014
    Applicants: BAYER PHARMA AKTIENGESELLSCHAFT, BAYER INTELLECTUAL PROPERTY GMBH
    Inventors: Jan Hübner, Rolf Bohlmann, Isabella Gashaw, Oliver Martin Fischer, Joachim Kuhnke, Norbert Gallus, Reinhard Nubbemeyer, Ildiko Terebesi
  • Estra-1,3,5(10),16-tetraene-3-carboxamide derivatives, processes for their preparation, pharmaceutical preparations comprising them and their use for preparing medicaments
    Publication number: 20140249119
    Abstract: The invention relates to AKR1C3 inhibitors and to processes for their preparation, to their use for the treatment and/or prophylaxis of diseases and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular bleeding disorders and endometriosis.
    Type: Application
    Filed: September 24, 2012
    Publication date: September 4, 2014
    Inventors: Ulrich Bothe, Naomi Barak, Matthias Busemann, Oliver Martin Fischer, Andrea Rotgeri, Isabella Gashaw, Ingo Hartung, Tobias Marquardt
  • MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ENDOMETRIOSIS
    Publication number: 20110003778
    Abstract: The present invention provides the use of mineralocorticoid receptor antagonists for preparing a medicament for the treatment of endometriosis. The present invention relates in particular to an improved therapeutic composition for endometriosis which has a more favorable activity and side-effect profile than treatment therapies currently available. Using a mineralocorticoid receptor antagonist, it is possible to threat endometriosis permanently without any loss of bone mass.
    Type: Application
    Filed: February 28, 2008
    Publication date: January 6, 2011
    Applicant: Bayer Schering Pharma Aktiengesellschaft
    Inventors: Carsten Moeller, Ulrike Kaufmann-Reiche, Anja Schmidt, Ulrike Fuhrmann, Oliver-Martin Fischer